News
Media
PodcastsCase Based Peer PerspectivesInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Laurie Erickson, MD

Advertisement

Articles by Laurie Erickson, MD

Simulation-based team training in obstetric emergencies

ByLaurie Erickson, MD,Kay Daniels, MD,Dena Goffman, MD,Pamela B. Andreatta, PhD,Jose F. Pliego, MD
May 1st 2012

Simulation training can prepare an obstetrical team for emergencies and provide a way to effectively review performance.

Advertisement

Latest Updated Articles

  • Simulation-based team training in obstetric emergencies
    Simulation-based team training in obstetric emergencies

    Published: May 1st 2012 | Updated:



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Contemporary OB/GYN week in review: FemVue clearance, flibanserin approval, and more

2

GSK, Spero Therapeutics resubmits NDA for tebipenem HBr as oral option for complicated urinary tract infections

3

FDA clears FemVue Controlled for in-office tubal assessment

4

Late-stage cervical cancer risk higher in older women

5

Objective blood loss measures reveal higher postpartum hemorrhage rates

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us